129 related articles for article (PubMed ID: 26492315)
1. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells.
Lauková J; Kozubík A; Hofmanová J; Nekvindová J; Sova P; Moyer MP; Ehrmann J; Hyršlová Vaculová A
PLoS One; 2015; 10(10):e0141020. PubMed ID: 26492315
[TBL] [Abstract][Full Text] [Related]
2. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
3. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.
Vondálová Blanářová O; Jelínková I; Hyršlová Vaculová A; Sova P; Hofmanová J; Kozubík A
Cell Prolif; 2013 Dec; 46(6):665-76. PubMed ID: 24118195
[TBL] [Abstract][Full Text] [Related]
4. Annona muricata leaves induce G₁ cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells.
Zorofchian Moghadamtousi S; Karimian H; Rouhollahi E; Paydar M; Fadaeinasab M; Abdul Kadir H
J Ethnopharmacol; 2014 Oct; 156():277-89. PubMed ID: 25195082
[TBL] [Abstract][Full Text] [Related]
5. Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo.
Dai Y; Qiao L; Chan KW; Zou B; Ma J; Lan HY; Gu Q; Li Z; Wang Y; Wong BL; Wong BC
Int J Cancer; 2008 Jun; 122(12):2858-63. PubMed ID: 18351648
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
7. Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
Herůdková J; Paruch K; Khirsariya P; Souček K; Krkoška M; Vondálová Blanářová O; Sova P; Kozubík A; Hyršlová Vaculová A
Neoplasia; 2017 Oct; 19(10):830-841. PubMed ID: 28888100
[TBL] [Abstract][Full Text] [Related]
8. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
[TBL] [Abstract][Full Text] [Related]
9. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
[TBL] [Abstract][Full Text] [Related]
10. Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin.
Horváth V; Soucek K; Svihálková-Sindlerová L; Vondrácek J; Blanárová O; Hofmanová J; Sova P; Kozubík A
Invest New Drugs; 2007 Oct; 25(5):435-43. PubMed ID: 17520175
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
12. Ceragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cells.
Kuroda K; Fukuda T; Okumura K; Yoneyama H; Isogai H; Savage PB; Isogai E
Anticancer Drugs; 2013 Sep; 24(8):826-34. PubMed ID: 23817390
[TBL] [Abstract][Full Text] [Related]
13. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
Vondálová Blanárová O; Jelínková I; Szöor A; Skender B; Soucek K; Horváth V; Vaculová A; Andera L; Sova P; Szöllosi J; Hofmanová J; Vereb G; Kozubík A
Carcinogenesis; 2011 Jan; 32(1):42-51. PubMed ID: 21037225
[TBL] [Abstract][Full Text] [Related]
15. The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.
Roubalová E; Kvardová V; Hrstka R; Borilová S; Michalová E; Dubská L; Müller P; Sova P; Vojtesek B
Invest New Drugs; 2010 Aug; 28(4):445-53. PubMed ID: 19499188
[TBL] [Abstract][Full Text] [Related]
16. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.
Teresi RE; Shaiu CW; Chen CS; Chatterjee VK; Waite KA; Eng C
Int J Cancer; 2006 May; 118(10):2390-8. PubMed ID: 16425225
[TBL] [Abstract][Full Text] [Related]
17. LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds.
Svihálková-Sindlerová L; Foltinová V; Vaculová A; Horváth V; Soucek K; Sova P; Hofmanová J; Kozubík A
Anticancer Res; 2010 Apr; 30(4):1183-8. PubMed ID: 20530425
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.
Schwab M; Reynders V; Loitsch S; Shastri YM; Steinhilber D; Schröder O; Stein J
Carcinogenesis; 2008 Jul; 29(7):1407-14. PubMed ID: 18544567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]